Loading...
XNAS
THRN
Oct 13, Last price  
10.19USD
Name

Thorne Healthtech Inc

Chart & Performance

D1W1MN
XNAS:THRN chart
P/E
35.13
P/S
2.41
EPS
0.29
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
229m
+23.47%
102,532,171138,454,924185,246,025228,731,362
Net income
16m
+49.15%
-16,592,492-2,444,10910,508,85615,674,040
CFO
5m
-42.52%
-7,620,87417,107,0559,084,2865,221,904

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to improve and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.
IPO date
Sep 23, 2021
Employees
544
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFY
2022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT